Clinical Research News Online
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • Press Releases
    • Post Press Releases
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Recorded Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • Clinical Trainings
    • Clinical Conferences
    • Clinical Trial Innovation Summit
    • Barnett International
  • About
    • Editorial Calendar
    • Editorial Profile
    • Contact Us
    • Submit a Story
  • SCOPE Summit
    • SCOPE Summit – US
    • SCOPE Summit – Europe
    • European Innovations Awards
 
 
 
 
  • Revisiting What Went Wrong In The Clinical Trial Tragedy In France

    Chemical & Engineering News |  In January 2016, one clinical trial volunteer in France died, four others were hospitalized, and two of those went on to have long-term neurological damage. Attempting to provide answers to what went wrong, a study published in Science now reports that the drug candidate responsible for the tragedy, BIA 10-2474, covalently binds several enzymes in addition to the fatty acid amide hydrolase (FAAH) it was designed to block.

    Jun 8, 2017
  • Polio Outbreak Is Reported In Syria, Health Officials Say

    STAT |  The new cases are vaccine-derived polioviruses and not an indication the viruses are spreading "in the wild," according to the WHO.

    Jun 8, 2017
  • Trump Announces He Will Keep Francis Collins As NIH Director

    STAT |  Dr. Francis Collins, a holdover from the Obama administration, will remain director of the National Institutes of Health, the White House announced.

    Jun 7, 2017
  • ‘All of Us’ Precision Medicine Initiative Begins Enrolling Beta Testers

    Healthcare Informatics |  The National Institutes of Health's precision medicine initiative, All of Us, has begun enrolling beta testers. The national launch of the initiative is anticipated for late fall or early next year.

    Jun 6, 2017
  • Loxo Oncology Seeks FDA Approval For Breakthrough Drug

    Forbes |  Loxo's therapy Larotrectinib demonstrates 76% confirmed objective response rate in TRK fusion adult and pediatric cancers as presented at the American Society of Clinical Oncology annual meeting.

    Jun 5, 2017
  • 23andMe Is Making Its First Foray into At-Home Research to Study Pain

    MIT Technology Review |  The genetic testing company wants customers to do an experiment to help uncover genetic links to pain.

    Jun 1, 2017
  • Population Health And Interoperability At Medical Informatics World

    Clinical Informatics News | Medical Informatics World kicked off last week in Boston with presentations on population health, telemedicine, and interoperability from Emory Healthcare, Beth Israel Deaconess Medical Center, and others.

    Jun 1, 2017
  • Boston Healthcare & dii Announce Global Life Sciences Data Commercialization Partnership

    Clinical Informatics News Brief | Boston Healthcare and Data Information Intelligence today announced a new partnership to develop and commercialize life sciences data and analytics for biopharmaceutical, medical device, and diagnostic companies.

    May 31, 2017
  • Medicare Patients Don't Share In Drug Discounts Given Insurers And PBMs

    STAT |  Medicare beneficiaries don't share in the discounts drug makers give to insurers and pharmacy benefit managers, according to a new paper.

    May 30, 2017
  • CluePoints, The Jackson Laboratory, Medidata, And More: News From May 2017

    Clinical Informatics News Brief | News, products, and partnerships from around the clinical trial and healthcare community including news from CluePoints, The Jackson Laboratory, Medidata, and more.

    May 30, 2017
  • CROS NT Announces Extended Partnership With Medidata - Deploys RaveX

    Clinical Informatics News Brief | CROS NT has announced the go-live of its RaveX team in an extension of the company’s partnership with Medidata. Under the partnership, CROS NT will offer its customers RaveX, as well as Medidata’s randomization and trial supply management (RTSM) system, Medidata Balance.

    May 26, 2017
  • «
  • 201
  • 202
  • 203 (current)
  • 204
  • 205
  • 206
  • 207
  • 208
  • 209
  • 210
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy